Cargando…
PB1887: STING AGONIST FOR THE TREATMENT OF RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA AND HIGH-RISK MYELODYSPLASTIC SYNDROME: A FIRST-IN-CLINIC PHASE 1 STUDY OF GSK3745417
Autores principales: | Montesinos, Pau, Al-Ali, Haifa Kathrin, Dominguez, Juan Manuel Alonso, Jentzsch, Madlen, Lavrencic, Mojca, Martelli, Maria Paola, Röllig, Christoph, Sica, Simona, Riham, Iadevaia, Yablonski, Kaitlin, Wang, Tianli, Mahmood, Zafar, Koenen, Giedre, Schmidt, Hank, Yang, Jingsing, Yee, Karen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430294/ http://dx.doi.org/10.1097/01.HS9.0000974372.45108.8e |
Ejemplares similares
-
1887
Publicado: (1888) -
Myelodysplastic syndromes: Biological and therapeutic consequences of the evolving molecular aberrations landscape
por: Schwind, Sebastian, et al.
Publicado: (2021) -
India in 1887
Publicado: (1888) -
Vale! 1887
Publicado: (1887) -
Strathpeffer Spa in 1887
Publicado: (1888)